![]() | Wick, M., Streel, S., Gizzi, M., Seront, E., Sacre, A., Seidel, L., & Gennigens, C. (November 2025). Lymph node metastases and survival outcomes in metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based therapies – A retrospective multicenter study. European Urology Open Science, 81, 297. doi:10.1016/s2666-1683(25)01672-6 Peer Reviewed verified by ORBi |
![]() | PETIT, E., Jerusalem, G., Denis, C., Wick, M., Freres, P., Gennigens, C., & Sautois, B. (September 2025). Les inhibiteurs de PARP (poly-ADP-ribose polymérase) : des nouveaux venus dans la prise en charge des cancers de la prostate. Revue Médicale de Liège, 80 (9), 592 - 597. Editorial Reviewed verified by ORBi |
![]() | Wick, M., Denis, C., Freres, P., Sautois, B., Waltregny, D., & Gennigens, C. (May 2025). Prise en charge du cancer du rein en 2025. Revue Médicale de Liège, 80 (5-6), 323 - 329. Editorial Reviewed verified by ORBi |
![]() | Wick, M., Sautois, B., Freres, P., Denis, C., Seidel, L., Waltregny, D., & Gennigens, C. (2024). Metastatic reanl cell carcinoma : monocentric retrospective data on first-line treatment. Belgian Journal of Medical Oncology. Peer Reviewed verified by ORBi |